Research

3D in vitro spheroid models, Liver Safety, Metabolic disease, Immune oncology, Organ-on-Chip Technology, 3D Cell Culture Technology

Interests

InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical industry. Founded in 2009, InSphero’s patent-pending technologies and methods enable large-scale, reproducible production of scaffold-free 3D microtissues for application in the field of liver safety, metabolic disease, and immune oncology. In recent years, innovative organ-on-chip concepts for automation-compatible multi-organ experiments have been presented, elevating in vitro testing to a next level of physiological relevance.